- Trials with a EudraCT protocol (4,999)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (77)
4,999 result(s) found for: Cells.
Displaying page 1 of 250.
EudraCT Number: 2018-004557-24 | Sponsor Protocol Number: UKM17_0056 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel | |||||||||||||
Full Title: Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis | |||||||||||||
Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003691-40 | Sponsor Protocol Number: LUMC2010-01 | Start Date*: 2012-09-19 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Administration of leukemia-reactive donor T cells after allogeneic stem cell transplantation or donor lymphocyte infusion to patients with persistent or relapsed mature B cell neoplasm with blood a... | ||
Medical condition: persistent or relapsed mature B cell neoplasm with blood and/or bone marrow involvement | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000054-63 | Sponsor Protocol Number: HNJ-NKAES-2012 | Start Date*: 2012-07-25 |
Sponsor Name:FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS | ||
Full Title: Salvage therapy with chemotherapy and Natural Killer cells in relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma. | ||
Medical condition: Relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014721-16 | Sponsor Protocol Number: IRRB/19/09 | Start Date*: 2009-11-18 |
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE | ||
Full Title: Controlled randomized pilot study for characterization and identification of CD34+ stem cells in the splancnic distrect after GCSF stimolation in cirrhotic patients | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-024625-20 | Sponsor Protocol Number: LUMC2010-02 | Start Date*: 2012-05-22 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: ADMINISTRATION OF HA-1 TCR TRANSDUCED VIRUS-SPECIFIC T-CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK LEUKEMIA (LUMC 2010-02) | ||
Medical condition: high risk leukemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-004043-36 | Sponsor Protocol Number: 004:TCELL | Start Date*: 2017-04-28 |
Sponsor Name:Uppsala University | ||
Full Title: CD19-TARGETING 3RD GENERATION CAR T CELLS FOR REFRACTORY B CELL MALIGNANCY – A PHASE II TRIAL | ||
Medical condition: CD19+ B cell lymphoma or leukemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001393-19 | Sponsor Protocol Number: 003:TCELL | Start Date*: 2014-04-08 |
Sponsor Name:Uppsala university | ||
Full Title: CD19-targeting 3rd generation CAR T cells for refractory B cell malignancy - a phase I/IIa trial. | ||
Medical condition: CD19+ B cell lymphoma or leukemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004310-33 | Sponsor Protocol Number: CAR4SAR | Start Date*: 2022-02-21 |
Sponsor Name:Dr. Antonio Pérez Martínez | ||
Full Title: A Phase I Trial of Memory T Cells Expressing an ANTI-NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults with Advanced Sarcoma | ||
Medical condition: Advanced Sarcoma | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024307-27 | Sponsor Protocol Number: LUMC2010-03 | Start Date*: 2011-11-01 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: TREATMENT WITH CMV PP65-SPECIFIC T CELLS GENERATED BY USE OF A CMV PP65 PROTEIN-SPANNING PEPTIDE POOL IN PATIENTS WITH CMV REACTIVATION OR CMV DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION | ||
Medical condition: CMV reactivation after allogeneic stem cell transplantation | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006649-18 | Sponsor Protocol Number: 08/0214 | Start Date*: 2011-11-16 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ... | |||||||||||||
Medical condition: CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg, AML, ALL, NHL, Hodgkin Lymphoma... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000280-28 | Sponsor Protocol Number: HHSC/002 | Start Date*: 2006-12-19 |
Sponsor Name:Imperial College London | ||
Full Title: A Phase I/II safety and tolerability dose escalation study following the autologous infusion of expanded adult haematopoietic stem cells to patients with established myocardial ischaemia. | ||
Medical condition: Established myocardial ischaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002492-17 | Sponsor Protocol Number: VISIT-V2 | Start Date*: 2016-06-17 | |||||||||||
Sponsor Name:St. Anna Kinderkrebsforschung | |||||||||||||
Full Title: Treatment of adenovirus and cytomegalovirus infection post human allogeneic stem cell transplantation with short-term expanded virus-specific T cells | |||||||||||||
Medical condition: Patients undergoing allogeneic HSCT undergo weekly screening for HAdV and CMV PCR. In case of viraemia ≥ 100 copies/ml PB preemptive antiviral with either Gancyclovir or Cidofovir conform to the ... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017924-18 | Sponsor Protocol Number: P10 | Start Date*: 2011-01-04 |
Sponsor Name: | ||
Full Title: Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual refractory angina pectoris and documented ischemia | ||
Medical condition: In coronary artery disease atherosclerosis leads to a decrease in lumen diameter of the large epicardial arteries, causing a deficit in blood flow known as ischemia. This ischemia can cause chest p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003574-28 | Sponsor Protocol Number: THYTECH1-2018-005 | Start Date*: 2019-11-26 |
Sponsor Name:Rafael Correa Rocha | ||
Full Title: Phase I / II clinical trial, randomized, exploratory and prospective to evaluate the safety and efficacy of the transfusion of autologous TREG cells obtained from thymic tissue in the prevention of... | ||
Medical condition: To evaluate the efficacy in the prevention of the rejection of the transfusion of autologous thyTreg cells in children transplanted from the heart | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005174-11 | Sponsor Protocol Number: U1111-1166-6923 | Start Date*: 2015-10-01 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: A randomized, double-blinded placebo-controlled, paralleled designed, investigator sponsored study of the effect of the GLP-1 receptor agonist liraglutide on beta-cell function in C-peptide positiv... | ||
Medical condition: Beta-cell function in C-peptide positive type 1 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2023-000061-14 | Sponsor Protocol Number: BCN04-DASA | Start Date*: 2023-05-26 | |||||||||||
Sponsor Name:Institut de Recerca Germans Trias i Pujol | |||||||||||||
Full Title: Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People with HIV under Antiretroviral Treatment | |||||||||||||
Medical condition: Human immunodeficiency virus (HIV) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000040-13 | Sponsor Protocol Number: 21011075118 | Start Date*: 2009-02-11 |
Sponsor Name:Medizinische Universität Innsbruck, Univ.-Klinik für Neurologie | ||
Full Title: Effects of recombinant human Erythropoietin on circulating and intramuscular endothelial progenitor cells, neovascularisation and oxidative metabolism of skeletal muscle in Friedreich’s Ataxia | ||
Medical condition: Friedreich's ataxia (FRDA) is the most common autosomal recessive neurodegenerativ disease (1:50 000) affecting the central and peripheral nervous system. Extraneural organs are also affected durin... | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004734-15 | Sponsor Protocol Number: EBio | Start Date*: 2019-06-03 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: EBIO – Enthesitis biopsy study | |||||||||||||
Medical condition: Psoriatic arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004073-27 | Sponsor Protocol Number: 18082A0002 | Start Date*: 2019-03-13 | |||||||||||
Sponsor Name:ARCI (trade name LYON RECHERCHE CLINIQUE : LyREC) | |||||||||||||
Full Title: Dupilumab impact on skin resident memory T cells | |||||||||||||
Medical condition: Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004368-21 | Sponsor Protocol Number: ISG-ACCesS | Start Date*: 2020-09-15 | |||||||||||
Sponsor Name:ITALIAN SARCOMA GROUP | |||||||||||||
Full Title: Phase II study on TSR-042 in advanced clear cells sarcoma | |||||||||||||
Medical condition: Advanced clear cells sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.